Wikidata

(Q61905063)

English

A Study to Evaluate the Safety, Tolerability and Efficacy of ILB in Patients With Amyotrophic Lateral Sclerosis

clinical trial

In more languages

Statements

title
A Single-centre, Open Single-arm Study Where the Safety, Tolerability and Efficacy of Subcutaneously Administered ILB Will be Evaluated in Patients With Amyotrophic Lateral Sclerosis (English)
0 references
sponsor
Tikomed (Sweden)
0 references
country
Sweden
0 references
start time
15 August 2018
0 references
end time
1 June 2019
0 references
number of participants
15
0 references
minimum age
18 year
0 references
maximum age
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61905063&oldid=2109491355"